English
中文
Top search
Atopic dermatitis Chronic prurigo Epidermolysis bullosa Psoriasis Immune-mediated kidney disease Glaucoma
Investor relations
Performance report Investor services
Investor relations

Browse news about PrimeGene to discover valuable information

Performance report
Beijing PrimeGene Science and Technology Co., Ltd. 2022

PrimeGene always sticks to the mission of “benefit patients, pray for health”, constantly enhances the construction of its capability of independent innovation and development, and is striving to become a domestically leading and globally competitive innovative pharmaceutical company and help people stay healthy.

Live preview Download PDF
Investor services

Floor 5&6, Tower B, Chongxin Building, Hangfeng Road 13#, Fengtai District, Beijing

Address

010-83141848

Investor hotline

IR@primegene.net

Investor email
About us
Approaching PrimeGene Coporate culture Development course Top management Honors & qualifications
Scientific research
Scientific and technological innovation Therapeutic area Product lines Win-win cooperation
News
Company News Industry trends
Recruitment
Philosophy on personnel Job duties
Get in touch with us
Floor 5&6, Tower B, Chongxin Building, Hangfeng Road 13#, Fengtai District, Beijing
010-83141848
Copyright owner：Prime Gene Therapeutics Co.,Ltd.
Copyright © 2023 All Rights Reserved.京ICP备2022001152号-1
Contact us Sitemap Privacy policy Legal statement